Brief: Strides Shasun To Launch Ranitidine OTC Tablets In U.S.
Feb 26 (Reuters) - Strides Shasun Ltd STSA.NS :
* TO LAUNCH RANITIDINE OTC TABLETS IN THE US MARKETS
* PRODUCT WILL BE MANUFACTURED AT THE JV'S (COMPANY'S 50:50
JV
WITH VIVIMED LABS) ORAL DOSAGE FACILITY IN CHENNAI
Source text: http://bit.ly/2oqiNHS
Further company coverage: STSA.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Vivimed Labs
See all newsBrief: Vivimed Labs Says Telangana High Court Grants Interim Stay On Proceedings
Brief: Vivimed Labs Ltd Phaninder Nath Resigns As CFO
Brief: Vivimed Labs CFO And CS Receive Notice From CBI
Brief: Vivimed Labs Says Got Notice From Debt Recovery Tribunal Regarding Application Filed By State Bank Of India
Brief: Vivimed Labs Names Ramakanta Tripathy As CFO